Introduction to pharmacology

45,384views

test

00:00 / 00:00

Introduction to pharmacology

my

my

Muscular system anatomy and physiology
Anatomy of the vertebral canal
Slow twitch and fast twitch muscle fibers
Brachial plexus
Sliding filament model of muscle contraction
Skeletal muscle histology
Lower back pain: Clinical
Back pain: Pathology review
Muscles of the back
Mesoderm
Myasthenia gravis
Cholinergic receptors
Adrenergic receptors
Alopecia: Clinical
Atopic dermatitis
Acne vulgaris
Local anesthetics
Muscles of the gluteal region and posterior thigh
Anatomy of the tibiofibular joints
Spinal muscular atrophy
Eczematous rashes: Clinical
Osteomalacia and rickets
Osteoporosis
Anatomy of the popliteal fossa
Paget disease of bone
Development of the axial skeleton
Anatomy of the anterior and medial thigh
Bone tumors
Bone tumors: Pathology review
Bone disorders: Pathology review
Oncogenes and tumor suppressor genes
Pediatric bone tumors: Clinical
Pediatric infectious rashes: Clinical
Anatomy clinical correlates: Bones, joints and muscles of the back
Bones of the vertebral column
Sciatica
Charcot-Marie-Tooth disease
Meniscus tear
Somatosensory receptors
Neuromuscular junction and motor unit
Osteoarthritis
Gout
Clostridium tetani (Tetanus)
Muscle spindles and golgi tendon organs
Vessels and nerves of the gluteal region and posterior thigh
Pediatric orthopedic conditions: Clinical
Achondroplasia
Diagnostic skills
Clinical Skills: Pulses assessment
Clinical Skills: Pulse oximetry
Clinical Skills: Respiratory rate assessment
Clinical Skills: Body Temperature Assessment
Clinical Skills: Obtaining blood pressure assessment
Osteoporosis medications
Osteogenesis imperfecta
Muscles of the forearm
Anatomy of the brachial plexus
Muscle contraction
Hashimoto thyroiditis
Hypothyroidism: Pathology review
Hyperthyroidism: Clinical
Rheumatoid arthritis and osteoarthritis: Pathology review
Joint pain: Clinical
Rheumatoid arthritis
Rheumatoid arthritis: Clinical
Gene regulation
Alpha-thalassemia
Beta-thalassemia
Bone remodeling and repair
Glycogen metabolism
Glycogen storage disease type I
Familial hypercholesterolemia
Hypercholesterolemia: Clinical
Sickle cell disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Intrinsic hemolytic normocytic anemia: Pathology review
Von Willebrand disease
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Factor V Leiden
Platelet disorders: Pathology review
Role of Vitamin K in coagulation
Transcription of DNA
DNA replication
Protein C deficiency
Spina bifida
Chiari malformation
Syringomyelia
Anatomy clinical correlates: Wrist and hand
Joints of the wrist and hand
Skin cancer
Epstein-Barr virus (Infectious mononucleosis)
Human papillomavirus
Human herpesvirus 8 (Kaposi sarcoma)
Anti-tumor antibiotics
Turner syndrome
Hyponatremia
Body fluid compartments
Hydration
Movement of water between body compartments
Dyslipidemias: Pathology review
Introduction to pharmacology
Medication overdoses and toxicities: Pathology review
Vibrio cholerae (Cholera)
Cell signaling pathways
Resting membrane potential
Thyroid hormones
Muscular dystrophy
Integumentary system: Skin lesions
Development of the muscular system
Bones of the upper limb
Bones of the lower limb
Anthelmintic medications
Streptococcus pyogenes (Group A Strep)
Mycobacterium tuberculosis (Tuberculosis)
Fatty acid oxidation
Nephrotic syndromes: Pathology review
Glomerular filtration
Nephritic and nephrotic syndromes: Clinical
Nephritic syndromes: Pathology review
Membranous nephropathy
Membranoproliferative glomerulonephritis
Cardiomyopathies: Clinical
ECG QRS transition

Assessments

USMLE® Step 1 questions

0 / 7 complete

USMLE® Step 2 questions

0 / 3 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 7 complete

USMLE® Step 2 style questions USMLE

0 of 3 complete

A 88-year-old man presents to the emergency department for new-onset confusion. The patient's daughter reports he was in his usual state of health until today when he was noted as “acting funny.” The patient has a past medical history of hypertension,  hyperlipidemia, diabetes, chronic back pain, coronary artery disease, and benign prostatic hyperplasia. His medications include hydrocodone, aspirin, prazosin, amlodipine, simvastatin, metformin, and sildenafil. He is normally alert, awake, and oriented to time, place, and person and requires only some assistance with activities of daily independent living. His temperature is 37.7°C (99.7°F), pulse is 94/min, respirations are 10/min, blood pressure is 130/64 mmHg, and O2 saturation is 96% on room air. Physical examination reveals an elderly male who appears confused. He states the year is “1964” and “Gerald Ford is the president of the United States.'' Neurologic examination is otherwise unremarkable. Abdominal examination reveals suprapubic tenderness to palpation, for which he is provided 2 mg of intravenous morphine. Urinalysis demonstrates 3+ bacteria with positive nitrite and leukocyte esterase. During his stay, he attempts to get out of bed several times and begins shouting at the nursing staff. Several attempts at verbal de-escalation, redirection, and reorientation are unsuccessful. Which of the following medications is the most appropriate given this patient’s clinical presentation?  

External References

First Aid

2024

2023

2022

2021

Androgen-receptor complex

pharmacologic control p. 673

Androstenedione p. 336, 646

pharmacologic control p. 673

Dihydrotestosterone (DHT)

pharmacologic control of p. 673

Estriol

pharmacologic control p. 673

Follicle-stimulating hormone (FSH)

pharmacologic control of p. 673

Luteinizing hormone (LH)

pharmacologic control of p. 673

Testosterone p. 646, 676

pharmacologic control p. 673

Transcript

Watch video only

Pharmacology is the study of medications, or chemical compounds, which interact with various living systems, from tiny molecules to cells, to tissues and whole organisms in order to produce a certain effect.

Every day, more and more new medications are designed to fight diseases, from infections to cancer, heart failure, and depression. But the process of developing a new medication can take a lot of time and money, and it typically consists of three steps. Step 1 is discovery, and that’s when a candidate compound is picked out as a possible therapeutic agent for a specific disease. Step 2 is preclinical research, during which this compound is tested on cell cultures and animals, like mice and rats, mainly to see if it causes any serious harm on living organisms. And, finally, step 3 is clinical development, during which clinical trials are performed. That’s where the compound is tested on humans to see if it’s safe and effective in treating diseases.

For a new medication, clinical trials are done in 4 phases, which can be remembered with the mnemonic “All medications need the SEAL of approval,” which stands for Safety, Efficacy, Approval, and Long term. Phase I trials test the medication in a small group of healthy individuals to see if it’s Safe for humans.

Phase II trials aim to find out more about how Effective the medication is or how well it works at a certain dose. This is done by testing it on a moderately sized group of individuals affected by the condition in question.

In phase III trials, the new medication is compared to the standard treatment to find out if it’s actually just as good as or even better than the existing one. Phase III trials generally involve a much larger number of individuals, and aim to replicate the exact setting in which the medication will be administered in real life, which will then be used as the basis for Approval by regulatory organizations for the market.

This whole process can take up to 10 years or more, depending on the compound. But if all this goes well- congratulations! We’ve got a new medication!

Now, that new medication will have at least three names- a chemical one, describing its chemical structure and used mostly in scientific studies, like N-acetyl-p-aminophenol; a generic name, which is usually a shortened version of the chemical name and is mostly used by health professionals, such as paracetamol or acetaminophen; and one or more brand or trade names, given by the pharmaceutical companies that make the medication, such as Panadol or Tylenol.

Okay, but the journey of drug development hasn’t finished quite yet. Once a medication reaches the marketplace, there’s phase IV, which is a final phase of safety surveillance that looks for Long term or rare side effects that might have been missed. If it’s found to be unsafe, a recall and ban might be needed.

Alright, now, once a medication is administered, it starts interacting with the body. This interaction can be broken down into pharmacokinetics and pharmacodynamics.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e" McGraw Hill / Medical (December 5, 2017)
  4. "First Aid for the USMLE Step 1 2020, Thirtieth edition" McGraw-Hill Education (2020)
  5. "Drug interactions: principles and practice" Aust Prescr (2012)
  6. "Pharmacodynamic Drug-Drug Interactions" Clinical pharmacology and therapeutics (2019)
  7. "When less is more – efficacy with less toxicity at the ED50" Br J Clin Pharmacol (2017)
  8. "The Drug Development Process " FDA (2021, August 2)